Skip to content
  • For US Healthcare Professionals

    Visit Patient Site
    Request a Representative or SamplesPrescribing InformationSee Schizophrenia Data
  • Request a Representative
    Order Samples
  • CAPLYTA® (lumateperone) for bipolar I and II depression homepage
    • Bipolar Depression
      • Indications
      • Primary Efficacy
      • Disease Severity
      • Quality of Life
      • Most Common Adverse Reactions
      • Weight and Metabolic Effects
      • EPS and Akathisia
    • Pharmacology
    • Dosing
    • Samples
      • Access
      • Savings Card
      • Expert Videos
      • Resources

    For US Healthcare Professionals

    See Schizophrenia DataVisit Patient Site

    Sitemap

    • Homepage
    • Bipolar Depression
    • Indications
    • Primary Efficacy
    • Disease Severity
    • Quality of Life
    • Most Common Adverse Reactions
    • Weight and Metabolic Effects
    • EPS and Akathisia
    • Pharmacology
    • Dosing
    • Samples
    • Access
    • Savings Card
    • Expert Videos
    • Resources
    Go to Intra-Cellular Therapies, Inc. homepage
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Contact Us
  • Disclosures
  • Sitemap
  • AdChoices Opt-out
  • CAPLYTA is a registered trademark, and LYTE THEIR WAY and LET IN THE LYTE are trademarks of Intra-Cellular Therapies, Inc.

    All other trademarks and registered trademarks are the property of their respective owners.

    © 2023 Intra-Cellular Therapies, Inc. All rights reserved. US-CAP-2200128 05/22